Evidence map›Paper›PMID 27267808›Full record

ArticleCancer letters2016

Developing oxygen-enhanced magnetic resonance imaging as a prognostic biomarker of radiation response.

Derek A White, Zhang Zhang, Li Li, Jeni Gerberich, Strahinja Stojadinovic, Peter Peschke, Ralph P Mason

Abstract read
In one paragraph

Article in Cancer letters, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 68 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Oxygen-Enhanced MRI Detects Incidence, Onset, and Heterogeneity of Radiation-Induced Hypoxia Modification in HPV-Associated Oropharyngeal Cancer.Clinical cancer research : an official journal of the American Association for Cancer Research · 2024
    Article
  8. Article
  9. Article
  10. Observational
  11. Review
  12. Article
  13. Review
  14. TThe British journal of radiology · 2023
    Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Oxygen-Sensitive MRI: A Predictive Imaging Biomarker for Tumor Radiation Response?International journal of radiation oncology, biology, physics · 2021
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Derek A WhiteDepartment of Radiology, UT Southwestern Medical Center, Dallas, Texas 75390, USA; Department of Bioengineering, University of Texas at Arlington, Arlington, Texas 76019, USA.
Zhang ZhangDepartment of Radiation Oncology, UT Southwestern Medical Center, Dallas, Texas 75390, USA.
Li LiDepartment of Radiology, UT Southwestern Medical Center, Dallas, Texas 75390, USA.
Jeni GerberichDepartment of Radiology, UT Southwestern Medical Center, Dallas, Texas 75390, USA.
Strahinja StojadinovicDepartment of Radiation Oncology, UT Southwestern Medical Center, Dallas, Texas 75390, USA.
Peter PeschkeGerman Cancer Center, Heidelberg, Germany.
Ralph P MasonDepartment of Radiology, UT Southwestern Medical Center, Dallas, Texas 75390, USA. Electronic address: Ralph.Mason@UTSouthwestern.edu.
Southwestern Medical Center · USGerman Cancer Research Center · DEThe University of Texas at Arlington · US

Funding

UT Southwestern Medical Center Simmons Comprehensive Cancer CenterP30CA142543 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI Sandi Leigh Pruitt · 2010 to 2026
$53.7M
TR&D 3: Imaging Carbohydrate MetabolismP41EB015908 · NIBIB · UT SOUTHWESTERN MEDICAL CENTER · PI MALLOY, CRAIG R · 2012 to 2021
$10.9M
Hypoxia and Radiotherapy: Evaluation and Mitigation in TumorsR01CA139043 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI MASON, RALPH P. · 2010 to 2014
$1.6M
X-RAD 225Cx Image Guided Biological Irradiator SystemS10RR028011 · NCRR · UT SOUTHWESTERN MEDICAL CENTER · PI SOLBERG, TIMOTHY · 2010 to 2010
$490k
NCI NIH HHS P30 CA142543NCI NIH HHS R01 CA139043NCRR NIH HHS S10 RR028011NIBIB NIH HHS P41 EB015908
6 · The paper itself

Abstract

Oxygen-Enhanced Magnetic Resonance Imaging (OE-MRI) techniques were evaluated as potential non-invasive predictive biomarkers of radiation response. Semi quantitative blood-oxygen level dependent (BOLD) and tissue oxygen level dependent (TOLD) contrast, and quantitative responses of relaxation rates (ΔR1 and ΔR2*) to an oxygen breathing challenge during hypofractionated radiotherapy were applied. OE-MRI was performed on subcutaneous Dunning R3327-AT1 rat prostate tumors (n=25) at 4.7 T prior to each irradiation (2F × 15 Gy) to the gross tumor volume. Response to radiation, while inhaling air or oxygen, was assessed by tumor growth delay measured up to four times the initial irradiated tumor volume (VQT). Radiation-induced hypoxia changes were confirmed using a double hypoxia marker assay. Inhaling oxygen during hypofractionated radiotherapy significantly improved radiation response. A correlation was observed between the difference in the 2nd and 1st ΔR1 (ΔΔR1) and VQT for air breathing rats. The TOLD response before the 2nd fraction showed a moderate correlation with VQT for oxygen breathing rats. The correlations indicate useful prognostic factors to predict tumor response to hypofractionation and could readily be applied for patient stratification and personalized radiotherapy treatment planning.

Indexed as

Radiation Dose HypofractionationTumor MicroenvironmentAnimalsBiomarkers, TumorImage Interpretation, Computer-AssistedMagnetic Resonance ImagingMaleNeoplasms, ExperimentalOxygenOxygen ConsumptionProstatic NeoplasmsRatsTime FactorsTumor BurdenTumor HypoxiaBiomarkers, TumorOxygenHypoxiaMagnetic resonance imagingOxygenRadiation responseReoxygenationStereotactic body radiation therapy (SBRT)

Identifiers

PMID27267808
PMCPMC4967391
OpenAlexW2413175974

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.